These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38661331)

  • 1. The Incidence of Cervical Intraepithelial Neoplasia or Cervical Cancer in Women Referred With Postcoital Bleeding.
    Mohammad H; Espensen AS; Arnardóttir MB; Bergholdt SH; Petersen LK
    J Low Genit Tract Dis; 2024 Jul; 28(3):210-216. PubMed ID: 38661331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papilloma Virus Typing as a Triage Tool for Women with Postcoital Bleeding: A Retrospective Cohort Study.
    Akdam A; Van Mil L; Tzur Y; Laskov I; Grisaru D; Schejter E; Michaan N
    J Womens Health (Larchmt); 2024 Jun; 33(6):734-740. PubMed ID: 38502831
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent post-coital bleeding: Should colposcopy still be mandatory?
    Tan JHJ; Jayasinghe YL; Osinski MJ; Brotherton JML; Wrede CDH
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):952-958. PubMed ID: 32914426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology.
    Sahu B; Latheef R; Aboel Magd S
    Arch Gynecol Obstet; 2007 Nov; 276(5):471-3. PubMed ID: 17429668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test.
    Booth BB; Tranberg M; Gustafson LW; Christiansen AG; Lapirtis H; Krogh LM; Hjorth IMD; Hammer A
    BMC Cancer; 2023 May; 23(1):405. PubMed ID: 37142959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cervical screening with high risk human papillomavirus testing: observational study.
    Rebolj M; Rimmer J; Denton K; Tidy J; Mathews C; Ellis K; Smith J; Evans C; Giles T; Frew V; Tyler X; Sargent A; Parker J; Holbrook M; Hunt K; Tidbury P; Levine T; Smith D; Patnick J; Stubbs R; Moss S; Kitchener H
    BMJ; 2019 Feb; 364():l240. PubMed ID: 30728133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
    Castle PE; Rodríguez AC; Burk RD; Herrero R; Wacholder S; Alfaro M; Morales J; Guillen D; Sherman ME; Solomon D; Schiffman M;
    BMJ; 2009 Jul; 339():b2569. PubMed ID: 19638649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
    Kipp B; Ulrich E; van Meegen C; Schwenzer T
    BMC Infect Dis; 2024 Jun; 24(1):558. PubMed ID: 38834951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
    Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
    Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is colposcopic evaluation necessary in all women with postcoital bleeding?
    Gulumser C; Tuncer A; Kuscu E; Ayhan A
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():83-7. PubMed ID: 26254856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype, cervical intraepithelial neoplasia, and type-specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women.
    Chen M; Ye Z; Wang H; Cui X; Seery S; Wu A; Xue P; Qiao Y
    J Med Virol; 2024 Mar; 96(3):e29475. PubMed ID: 38415472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.
    Berger L; Wolf-Breitinger M; Weiß C; Tuschy B; Berlit S; Sütterlin M; Spaich S
    Cancer Causes Control; 2023 May; 34(5):469-477. PubMed ID: 36854989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
    Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
    Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study.
    Lindquist S; Kjær SK; Frederiksen K; Ørnskov D; Petersen LK; Munk C; Waldstrøm M
    Acta Obstet Gynecol Scand; 2024 Sep; 103(9):1781-1788. PubMed ID: 39012789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.